| Primary Device ID | 04048474051889 | 
| NIH Device Record Key | a6f80900-58ef-4db6-ade5-3d5e4e623c80 | 
| Commercial Distribution Status | In Commercial Distribution | 
| Brand Name | Coxiella burnetii (Q-Fever) Phase 1 IgG ELISA | 
| Version Model Number | EIA-5188 | 
| Catalog Number | EIA-5188 | 
| Company DUNS | 317134468 | 
| Company Name | DRG Instruments Gesellschaft mit beschränkter Haftung | 
| Device Count | 1 | 
| DM Exempt | false | 
| Pre-market Exempt | true | 
| MRI Safety Status | MR Conditional | 
| Human Cell/Tissue Product | false | 
| Device Kit | true | 
| Device Combination Product | false | 
| Single Use | true | 
| Lot Batch | true | 
| Serial Number | false | 
| Manufacturing Date | true | 
| Expiration Date | true | 
| Donation Id Number | false | 
| Contains Natural Rubber Latex | false | 
| Labeled No Natural Rubber Latex | false | 
| RX Perscription | true | 
| OTC Over-The-Counter | false | 
| Phone | 973-564-7555 | 
| corp@drg-international.com | |
| Phone | 973-564-7555 | 
| corp@drg-international.com | |
| Phone | 973-564-7555 | 
| corp@drg-international.com | |
| Phone | 973-564-7555 | 
| corp@drg-international.com | |
| Phone | 973-564-7555 | 
| corp@drg-international.com | |
| Phone | 973-564-7555 | 
| corp@drg-international.com | |
| Phone | 973-564-7555 | 
| corp@drg-international.com | |
| Phone | 973-564-7555 | 
| corp@drg-international.com | |
| Phone | 973-564-7555 | 
| corp@drg-international.com | |
| Phone | 973-564-7555 | 
| corp@drg-international.com | |
| Phone | 973-564-7555 | 
| corp@drg-international.com | |
| Phone | 973-564-7555 | 
| corp@drg-international.com | |
| Phone | 973-564-7555 | 
| corp@drg-international.com | |
| Phone | 973-564-7555 | 
| corp@drg-international.com | |
| Phone | 973-564-7555 | 
| corp@drg-international.com | |
| Phone | 973-564-7555 | 
| corp@drg-international.com | |
| Phone | 973-564-7555 | 
| corp@drg-international.com | |
| Phone | 973-564-7555 | 
| corp@drg-international.com | 
| Storage Environment Temperature | Between 2 Degrees Celsius and 8 Degrees Celsius | 
| Storage Environment Temperature | Between 2 Degrees Celsius and 8 Degrees Celsius | 
| Storage Environment Temperature | Between 2 Degrees Celsius and 8 Degrees Celsius | 
| Storage Environment Temperature | Between 2 Degrees Celsius and 8 Degrees Celsius | 
| Storage Environment Temperature | Between 2 Degrees Celsius and 8 Degrees Celsius | 
| Storage Environment Temperature | Between 2 Degrees Celsius and 8 Degrees Celsius | 
| Storage Environment Temperature | Between 2 Degrees Celsius and 8 Degrees Celsius | 
| Storage Environment Temperature | Between 2 Degrees Celsius and 8 Degrees Celsius | 
| Storage Environment Temperature | Between 2 Degrees Celsius and 8 Degrees Celsius | 
| Storage Environment Temperature | Between 2 Degrees Celsius and 8 Degrees Celsius | 
| Storage Environment Temperature | Between 2 Degrees Celsius and 8 Degrees Celsius | 
| Storage Environment Temperature | Between 2 Degrees Celsius and 8 Degrees Celsius | 
| Storage Environment Temperature | Between 2 Degrees Celsius and 8 Degrees Celsius | 
| Storage Environment Temperature | Between 2 Degrees Celsius and 8 Degrees Celsius | 
| Storage Environment Temperature | Between 2 Degrees Celsius and 8 Degrees Celsius | 
| Storage Environment Temperature | Between 2 Degrees Celsius and 8 Degrees Celsius | 
| Storage Environment Temperature | Between 2 Degrees Celsius and 8 Degrees Celsius | 
| Storage Environment Temperature | Between 2 Degrees Celsius and 8 Degrees Celsius | 
| Device Issuing Agency | Device ID | 
|---|---|
| GS1 | 04048474051889 [Primary] | 
| GPR | Antiserum, Cf, Q Fever | 
| Steralize Prior To Use | false | 
| Device Is Sterile | false | 
| Public Version Status | New | 
| Device Record Status | Published | 
| Public Version Number | 1 | 
| Public Version Date | 2023-09-11 | 
| Device Publish Date | 2023-09-01 | 
| 00404847451887 | The Coxiella burnetii (Q-Fever) Phase 1 IgG ELISA is intended for the qualitative determination | 
| 04048474051889 | The Coxiella burnetii (Q-Fever) Phase 1 IgG ELISA is intended for the qualitative determination |